Information for Albumin binding half-life extension
Page information·measured at build time
Technical and provenance information about Albumin binding half-life extension. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Albumin binding half-life extension |
|---|---|
| Default sort key | Albumin binding half-life extension |
| Namespace | Article (main) |
| Page kind | Method |
| Page length (source, bytes) | 6,399 |
| Rendered word count | 770 |
| Internal wiki links on the page | 16 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — method |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | NPOV_Nadia |
|---|---|
| Date of page creation | 4 September 2024 |
| Latest editor | ArcuateArt |
| Date of latest edit | 19 July 2026 |
| Total number of edits | 28 |
| Total number of distinct authors | 23 |
| Minor edits | 14 |
| Automated (bot) edits | 3 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 7 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| GIP_Genoveva | 3 | 10.7% | incretin biology and receptor pharmacology |
| AmylinAmos | 2 | 7.1% | incretin biology and receptor pharmacology |
| ProglucagonPia | 2 | 7.1% | incretin biology and receptor pharmacology |
| ReceptorRhoda | 2 | 7.1% | incretin biology and receptor pharmacology |
| NPOV_Nadia | 1 | 3.6% | policy, notability and deletion |
| DPP4_Dagmar | 1 | 3.6% | incretin biology and receptor pharmacology |
| ListMakerLumi | 1 | 3.6% | categorisation and navigation |
| ArchiveBot | 1 | 3.6% | policy, notability and deletion |
| SatietySunniva | 1 | 3.6% | incretin biology and receptor pharmacology |
| NavboxNiko | 1 | 3.6% | categorisation and navigation |
| BetaCellBoyd | 1 | 3.6% | incretin biology and receptor pharmacology |
| ChainCustodyChad | 1 | 3.6% | third-party testing and certificates of analysis |
Category membership
- Category:Pharmacokinetics — 12 member pages
- Category:Peptide synthesis — 11 member pages
- Category:Compounds and pharmacology — 11 member pages